Open | $0.498 |
Close | $0.485 |
Volume / Avg. | 162.948K / 202.739K |
Day Range | 0.451 - 0.498 |
52 Wk Range | 0.165 - 3.840 |
Market Cap | $4.718M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 49 |
Short Interest | 0.45% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of OpGen (NASDAQ: OPGN) through any online brokerage.
Other companies in OpGen’s space includes: Alzamend Neuro (NASDAQ:ALZN), Virios Therapeutics (NASDAQ:VIRI), Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX) and Geovax Labs (NASDAQ:GOVX).
The latest price target for OpGen (NASDAQ: OPGN) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 0.00 expecting OPGN to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.
The stock price for OpGen (NASDAQ: OPGN) is $0.4712 last updated March 18, 2024 at 7:49 PM EDT.
There are no upcoming dividends for OpGen.
OpGen’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for OpGen.
OpGen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.